Theiagen provides
- Workflow design for C. auris-focused analysis
- QC and review checkpoints
- Relatedness interpretation structure
- Customer-ready report and technical appendix
Fixed-scope commercial pilots
Pick a pilot that answers a real launch question.
The right first project should prove a workflow, an output, and a commercial service concept. These pilots are designed to create useful evidence quickly without pretending that a pilot is a full validation.
Pilot comparison
Three practical paths into pathogen-genomics service development.
| Option | Best when | Primary output | Launch question answered |
|---|---|---|---|
| C. auris transmission intelligence | Your lab wants to evaluate fungal outbreak or transmission-related reporting. | Sample workflow, relatedness review model, report structure, and operational requirements. | Can we turn sequencing into a customer-facing infection prevention service? |
| AMR / CRE cluster intelligence | Your customers need antimicrobial resistance, cluster, or relatedness insight beyond routine results. | AMR evidence map, cluster review structure, technical appendix, and escalation model. | Can we package genomic context into a defensible intelligence product? |
| Pathogen-genomics launch package | You are planning a broader commercial pathogen-genomics service line. | Service-line roadmap, validation planning structure, output package, and team enablement plan. | What would it take to launch this service credibly? |
Pilot 01
C. auris transmission intelligence pilot
A focused pilot for labs evaluating healthcare-associated fungal threat reporting, outbreak investigation support, or infection prevention intelligence services.
Your team provides
- Target customer and use-case context
- Representative sample or historical data plan, when available
- Operational constraints and validation expectations
- Scientific, lab operations, and commercial reviewers
Pilot 02
AMR / CRE cluster intelligence pilot
A pilot for commercial labs that want to explore resistance and cluster reporting as a differentiated service for hospitals, infection prevention, stewardship, or surveillance customers.
Theiagen provides
- AMR and cluster reporting framework
- Evidence trail and QC review structure
- Customer-facing output examples
- Operational model for review, escalation, and support
Your team provides
- Priority organism or resistance scenario
- Current lab workflow and result-reporting constraints
- Customer pain points and decision context
- Reviewers from scientific and commercial teams
Pilot 03
Commercial lab pathogen-genomics launch package
A launch-readiness engagement for labs that want to define the service menu, operating requirements, validation path, output package, and team enablement plan before committing to buildout.
Theiagen provides
- Service-line strategy and workflow roadmap
- Validation planning structure
- Report and technical appendix templates
- Training and support model for launch
Your team provides
- Commercial priorities and customer segments
- Existing lab capabilities and launch constraints
- Stakeholders for scientific, operational, and commercial review
- Decision criteria for moving beyond pilot
Pilot deliverables
Concrete artifacts your lab can use to decide, validate, and launch.
Workflow map
Inputs, metadata, QC, workflow versions, review steps, and output handoffs.
Output example
Executive summary, technical appendix, and customer-facing report structure.
Validation plan
Questions, evidence categories, documentation expectations, and review model.
Launch recommendation
Feasibility, customer fit, operating needs, risks, and next-step roadmap.
Pilot fit
Start with the use case your customers are already asking about.
Theiagen can help you narrow the scope and define what a useful pilot should prove.
Request a pilot consult
Bring your target pathogen, customer segment, or service-line hypothesis. We will help shape the right first project.